Concepedia

Vasiliki Leventaki

VL

33

Publications

2.1K

Citations

26

H-Index

2002

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

St. Jude Children's Research Hospital

National and Kapodistrian University of Athens

University of Utah

Huntsman Cancer Institute

Vasiliki Leventaki is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyImmunologyTumor BiologyCell SignalingPathologyCell DeathCancer ResearchOncologyCancer Biology

Publications per year

2002–2019

33

Publications

33

Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma

Francisco Vega, L. Jeffrey Medeiros, Vasiliki Leventaki et al. · Cancer Research · 2006 · 195 citations · Full text

Tumor Cell Survival, Immunology, Mtor Pathway +20

Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma

Hesham M. Amin, Timothy J. McDonnell, Yupo Ma et al. · Oncogene · 2004 · 166 citations

Selective Inhibition, Lymphoid Neoplasia, Hematological Malignancy +12

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma

Hesham M. Amin, L. Jeffrey Medeiros, Yupo Ma et al. · Oncogene · 2003 · 128 citations

Lymphoid Neoplasia, Jak3 Induces Apoptosis, Medicine +10

Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma

Evangelia Peponi, Guadalupe Reyes, Vasiliki Leventaki et al. · American Journal Of Pathology · 2006 · 118 citations · Full text

Cancer Research, Mammalian Target, Signaling Pathway +11

Characterization of 4 mantle cell lymphoma cell lines.

Hesham M. Amin, Timothy J. McDonnell, L. Jeffrey Medeiros et al. · PubMed · 2003 · 114 citations

Rows per page

1–5 of 33